Your browser doesn't support javascript.
loading
An Integrative Scoring System for Survival Prediction Following Umbilical Cord Blood Transplantation in Acute Leukemia.
Shouval, Roni; Ruggeri, Annalisa; Labopin, Myriam; Mohty, Mohamad; Sanz, Guillermo; Michel, Gerard; Kuball, Jürgen; Chevallier, Patrice; Al-Seraihy, Amal; Milpied, Noel-Jean; de Heredia, Cristina Diaz; Arcese, William; Blaise, Didier; Rocha, Vanderson; Fein, Joshua; Unger, Ron; Baron, Frederic; Bader, Peter; Gluckman, Eliane; Nagler, Arnon.
Afiliação
  • Shouval R; Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-HaShomer, Ramat-Gan, Israel. shouval@gmail.com.
  • Ruggeri A; Dr. Pinchas Bornstein Talpiot Medical Leadership Program, Chaim Sheba Medical Center, Tel-HaShomer, Ramat-Gan, Israel.
  • Labopin M; Sackler Faculty of Medicine, Tel-Aviv University, Israel.
  • Mohty M; Bar-Ilan University, Ramat Gan, Israel.
  • Sanz G; Service d'Hématologie Clinique et de Thérapie Cellulaire, Hôpital Saint-Antoine, Paris, France.
  • Michel G; Eurocord, Hospital Saint Louis, Paris, France.
  • Kuball J; Service d'Hématologie Clinique et de Thérapie Cellulaire, Hôpital Saint-Antoine, Paris, France.
  • Chevallier P; Acute Leukemia Working Party EBMT Paris Office, Hôpital Saint-Antoine, Paris, France.
  • Al-Seraihy A; Service d'Hématologie Clinique et de Thérapie Cellulaire, Hôpital Saint-Antoine, Paris, France.
  • Milpied NJ; Universite Pierre et Marie Curie, Paris, France.
  • de Heredia CD; Hospital Universitario La Fe, Valencia, Spain.
  • Arcese W; Timone Enfants Hospital and Aix-Marseille University, Marseille, France.
  • Blaise D; University Medical Centre Utrecht, Utrecht, the Netherlands.
  • Rocha V; CHU Nantes, Nantes, France.
  • Fein J; King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia.
  • Unger R; Hôpital du Haut Leveque, Bordeaux, France.
  • Baron F; Hospital Vall d'Hebron, Barcelona, Spain.
  • Bader P; University of Rome 'Tor Vergata', Rome, Italy.
  • Gluckman E; Institut Paoli Calmettes, Marseille, France.
  • Nagler A; Eurocord, Hospital Saint Louis, Paris, France.
Clin Cancer Res ; 23(21): 6478-6486, 2017 Nov 01.
Article em En | MEDLINE | ID: mdl-28754820
ABSTRACT

Purpose:

Survival of acute leukemia (AL) patients following umbilical cord blood transplantation (UCBT) is dependent on an array of individual features. Integrative models for risk assessment are lacking. We sought to develop a scoring system for prediction of overall survival (OS) and leukemia-free survival (LFS) at 2 years following UCBT in AL patients.Experimental

Design:

The study cohort included 3,140 pediatric and adult AL UCBT patients from the European Society of Blood and Marrow Transplantation and Eurocord registries. Patients received single or double cord blood units. The dataset was geographically split into a derivation (n = 2,362, 65%) and validation set (n = 778, 35%). Top predictors of OS were identified using the Random Survival Forest algorithm and introduced into a Cox regression model, which served for the construction of the UCBT risk score.

Results:

The score includes nine variables disease status, diagnosis, cell dose, age, center experience, cytomegalovirus serostatus, degree of HLA mismatch, previous autograft, and anti-thymocyte globulin administration. Over the validation set an increasing score was associated with decreasing probabilities for 2 years OS and LFS, ranging from 70.21% [68.89-70.71, 95% confidence interval (CI)] and 64.76% (64.33-65.86, 95% CI) to 14.78% (10.91-17.41) and 18.11% (14.40-22.30), respectively. It stratified patients into six distinct risk groups. The score's discrimination (AUC) over multiple imputations of the validation set was 68.76 (68.19-69.04, range) and 65.78 (65.20-66.28) for 2 years OS and LFS, respectively.

Conclusions:

The UCBT score is a simple tool for risk stratification of AL patients undergoing UCBT. Widespread application of the score will require further independent validation. Clin Cancer Res; 23(21); 6478-86. ©2017 AACR.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Prognóstico / Leucemia Mieloide Aguda / Transplante de Células-Tronco de Sangue do Cordão Umbilical Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Female / Humans / Male Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Israel

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Prognóstico / Leucemia Mieloide Aguda / Transplante de Células-Tronco de Sangue do Cordão Umbilical Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Female / Humans / Male Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Israel